Guidetti, Clotilde

REL-1017 (Esmethadone) as Adjunctive Treatment in Patients With Major Depressive Disorder: A Phase 2a Randomized Double-Blind Trial

Fava, M., Stahl, S., Pani, L., De Martin, S., Pappagallo, M., Guidetti, C., Alimonti, A., Bettini, E., Mangano, R. M., Wessel, T., et al. (2022) · American Journal of Psychiatry

Treatment of Major DepressionNeuroscience and Neuropharmacology Research

Cited by 83

Subanalysis of Subjective Cognitive Measures From a Phase 2, Double-Blind, Randomized Trial of REL-1017 in Patients With Major Depressive Disorder

Guidetti, C., Serra, G., Pani, L., Pappagallo, M., Maglio, G., Martin, S. D., Mattarei, A., Folli, F., Manfredi, P. L., & Fava, M. (2023) · The Primary Care Companion For CNS Disorders

Treatment of Major DepressionSchizophrenia research and treatment

Cited by 4

A Phase 2a Double-Blind Randomized Trial of REL-1017 (Esmethadone) in Patients with MDD: Analysis of Subscales from the Symptoms of Depression Questionnaire

Guidetti, C., Fava, M., Pani, L., Pappagallo, M., Serra, G., DeMartin, S., Mattarei, A., & Manfredi, P. L. (2022) · CNS Spectrums

Treatment of Major DepressionBipolar Disorder and Treatment

Cited by 3